Serum insulin-like growth factor binding protein 3 as a promising diagnostic and prognostic biomarker in esophagogastric junction adenocarcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2730-6011
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Serum insulin-like growth factor binding protein 3 as a promising diagnostic and prognostic biomarker in esophagogastric junction adenocarcinoma ; volume:13 ; number:1 ; day:21 ; month:11 ; year:2022 ; pages:1-14 ; date:12.2022
Discover oncology ; 13, Heft 1 (21.11.2022), 1-14, 12.2022
- Urheber
-
Ding, Tian-Yan
Peng, Yu-Hui
Hong, Chao-Qun
Huang, Bin-Liang
Liu, Can-Tong
Luo, Yun
Chu, Ling-Yu
Zhang, Biao
Li, Xin-Hao
Qu, Qi-Qi
Xu, Yi-Wei
Wu, Fang-Cai
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12672-022-00591-1
- URN
-
urn:nbn:de:101:1-2023020221063334812923
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ding, Tian-Yan
- Peng, Yu-Hui
- Hong, Chao-Qun
- Huang, Bin-Liang
- Liu, Can-Tong
- Luo, Yun
- Chu, Ling-Yu
- Zhang, Biao
- Li, Xin-Hao
- Qu, Qi-Qi
- Xu, Yi-Wei
- Wu, Fang-Cai
- SpringerLink (Online service)
Ähnliche Objekte (12)
![Adenocarcinoma of the esophagogastric junction : [indexed in PubMed/Medline]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Adenocarcinoma of the esophagogastric junction : [indexed in PubMed/Medline]
Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction
Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma
Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction
Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study
Novel therapeutic endoscope facilitates endoscopic submucosal dissection of adenocarcinoma at the esophagogastric junction
The correlation between the margin of resection and prognosis in esophagogastric junction adenocarcinoma
Comparative single-cell analysis reveals heterogeneous immune landscapes in adenocarcinoma of the esophagogastric junction and gastric adenocarcinoma
Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction
Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction
Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma
A retrospective analysis of lymph node dissection in Siewert II adenocarcinoma of the esophagogastric junction
Adenocarcinoma of the esophagogastric junction : [indexed in PubMed/Medline]
Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction
Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma
Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction
Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study
Novel therapeutic endoscope facilitates endoscopic submucosal dissection of adenocarcinoma at the esophagogastric junction
The correlation between the margin of resection and prognosis in esophagogastric junction adenocarcinoma
Comparative single-cell analysis reveals heterogeneous immune landscapes in adenocarcinoma of the esophagogastric junction and gastric adenocarcinoma
Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction
Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction
Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma
A retrospective analysis of lymph node dissection in Siewert II adenocarcinoma of the esophagogastric junction
Adenocarcinoma of the esophagogastric junction : [indexed in PubMed/Medline]
Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction
Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma
Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction
Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study
Novel therapeutic endoscope facilitates endoscopic submucosal dissection of adenocarcinoma at the esophagogastric junction
The correlation between the margin of resection and prognosis in esophagogastric junction adenocarcinoma
Comparative single-cell analysis reveals heterogeneous immune landscapes in adenocarcinoma of the esophagogastric junction and gastric adenocarcinoma
Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction
Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction
Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma